Literature DB >> 2432026

Isolation of the human T-cell leukemia/lymphotropic virus type III from aqueous humor in two patients with perivasculitis of the retinal vessels.

P Kestelyn, P Van de Perre, S Sprecher-Goldberger.   

Abstract

The human T-cell leukemia/lymphotropic virus type III (HTLV-III) has been isolated from aqueous humor in two patients with perivasculitis of the peripheral retinal vessels, an AIDS-related ocular manifestation. Both patients had antibodies to HTLV-III and although they presented with herpes zoster ophthalmicus, they did not present other symptoms known to be associated with HTLV-III infection. The isolation of HTLV-III from aqueous humor in these two patients with retinal perivasculitis suggests that the virus itself may play a role in the etiology of this ocular sign. The presence of infectious HTLV-III in the anterior chamber further emphasises the necessity to discard corneas from HTLV-III infected donors.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2432026     DOI: 10.1007/bf00137538

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  21 in total

1.  The impact of the AIDS epidemic on corneal transplantation.

Authors:  J S Pepose; S Mac Rae; T C Quinn; G N Holland
Journal:  Am J Ophthalmol       Date:  1985-10-15       Impact factor: 5.258

2.  Isolation of AIDS virus from cell-free breast milk of three healthy virus carriers.

Authors:  L Thiry; S Sprecher-Goldberger; T Jonckheer; J Levy; P Van de Perre; P Henrivaux; J Cogniaux-LeClerc; N Clumeck
Journal:  Lancet       Date:  1985-10-19       Impact factor: 79.321

3.  Perivasculitis of the retinal vessels as an important sign in children with AIDS-related complex.

Authors:  P Kestelyn; P Lepage; P Van de Perre
Journal:  Am J Ophthalmol       Date:  1985-10-15       Impact factor: 5.258

4.  HTLV-III infection in brains of children and adults with AIDS encephalopathy.

Authors:  G M Shaw; M E Harper; B H Hahn; L G Epstein; D C Gajdusek; R W Price; B A Navia; C K Petito; C J O'Hara; J E Groopman
Journal:  Science       Date:  1985-01-11       Impact factor: 47.728

5.  Isolation of AIDS-associated retroviruses from cerebrospinal fluid and brain of patients with neurological symptoms.

Authors:  J A Levy; J Shimabukuro; H Hollander; J Mills; L Kaminsky
Journal:  Lancet       Date:  1985-09-14       Impact factor: 79.321

6.  HTLV-III in saliva of people with AIDS-related complex and healthy homosexual men at risk for AIDS.

Authors:  J E Groopman; S Z Salahuddin; M G Sarngadharan; P D Markham; M Gonda; A Sliski; R C Gallo
Journal:  Science       Date:  1984-10-26       Impact factor: 47.728

7.  Isolation of HTLV-III from cerebrospinal fluid and neural tissues of patients with neurologic syndromes related to the acquired immunodeficiency syndrome.

Authors:  D D Ho; T R Rota; R T Schooley; J C Kaplan; J D Allan; J E Groopman; L Resnick; D Felsenstein; C A Andrews; M S Hirsch
Journal:  N Engl J Med       Date:  1985-12-12       Impact factor: 91.245

8.  Intra-blood-brain-barrier synthesis of HTLV-III-specific IgG in patients with neurologic symptoms associated with AIDS or AIDS-related complex.

Authors:  L Resnick; F diMarzo-Veronese; J Schüpbach; W W Tourtellotte; D D Ho; F Müller; P Shapshak; M Vogt; J E Groopman; P D Markham
Journal:  N Engl J Med       Date:  1985-12-12       Impact factor: 91.245

9.  Human T-cell leukemia/lymphotropic virus type III in the conjunctival epithelium of a patient with AIDS.

Authors:  L S Fujikawa; S Z Salahuddin; D Ablashi; A G Palestine; H Masur; R B Nussenblatt; R C Gallo
Journal:  Am J Ophthalmol       Date:  1985-10-15       Impact factor: 5.258

10.  HTLV-III in the semen and blood of a healthy homosexual man.

Authors:  D D Ho; R T Schooley; T R Rota; J C Kaplan; T Flynn; S Z Salahuddin; M A Gonda; M S Hirsch
Journal:  Science       Date:  1984-10-26       Impact factor: 47.728

View more
  1 in total

Review 1.  Ocular problems in AIDS.

Authors:  P Kestelyn
Journal:  Int Ophthalmol       Date:  1990-05       Impact factor: 2.031

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.